SNMMI Annual Meeting Highlights History, Looks to Future

June 13, 2013

SNMMI Annual Meeting Highlights History, Looks to Future

SNMMI Annual Meeting Highlights History, Looks to Future

Society celebrates 60th Annual Meeting; showcases new research and technology

Reston, Va.—Thousands of physicians, technologists, physicists, scientists and exhibitors gathered at the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2013 Annual Meeting, held June 8-12 in Vancouver, British Columbia. In addition to the more than 110 continuing education sessions, more than 2,000 scientific papers and posters were presented at the meeting and 150 companies were represented on the exhibit hall floor.

The Annual Meeting opened with the SNMMI plenary session on Sunday, June 9, as Val Lewington, MD, of Guy’s & St. Thomas’ National Health Service Foundation Trust in London, presented the Henry N. Wagner Jr, MD, Lecture, “Moving Molecular Radiotherapy into the Mainstream: Have We Reached the Tipping Point?” Later that day, Josh Mailman, a patient advocate, presented “Many the Miles—A Patient's Journey for Better Outcomes” at the SNMMI Technologist Section plenary.

SNMMI honored several leaders in the field at its two plenary sessions. S. Ted Treves, MD, professor of radiology (nuclear medicine) and director of the Joint Program in Nuclear Medicine (JPNM) at Harvard Medical School, was named as this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. Dean F. Wong, MD, PhD, professor and vice chair of Radiology, and professor of Psychiatry, Neuroscience, Environmental Health Sciences, and Carey School of Business at Johns Hopkins University (JHU) in Baltimore, Md., received the prestigious Paul C. Aebersold Award for achievement in basic nuclear medicine.

Monday’s special plenary session welcomed a new leadership team for SNMMI as Dillehay became president, while Peter Herscovitch, MD, assumed the position of president-elect andHossein Jadvar, MD, PhD, MPH, MBA, FACNM,the vice president-elect position. The leadership for SNMMI’s Technologist Section also changed hands during the meeting, with Scott Holbrook, BS, CNMT, FSNMTS, taking the helm as president and April Mann, NCT, RT(N), FSNMMI-TS, as president-elect.

Also announced was the SNMMI 2013 Image of the Year. The honor was given to Patrick Flamen, MD, PhD, and his colleagues for their image (scientific paper 647)—an 18F-FDG positron emission tomography/computed tomography (PET/CT) scan illustrating the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease.

SNMMI also held a Patient Program at the Annual Meeting where more than 75 patients and caregivers attended sessions on advances in nuclear medicine and molecular imaging. Topics featured included dementia, neuroendocrine tumors and lymphoma.

Back by popular demand, SNMMI is offering its Virtual Meeting for those unable to attend certain sessions or make the trip to Vancouver. The Virtual Meeting captured70 of the most popular sessions, featuringmore than 100 hours of content from the opening plenary through the Highlights Session, plus the molecular imaging, radiopharmaceutical, and data and instrumentation basic science summary sessions. CME, ACPE and VOICE credits are available through the Virtual Meeting.

The SNMMI 2014 Annual Meeting will take place June 7-11 in St. Louis, MO. For more information, visit


About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI’s more than 19,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit


Related Items